Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
72°
Mostly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
905.59
-36.01 (-3.82%)
Official Closing Price
Updated: 4:10 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
98
99
Next >
Palantir, Nvidia, Eli Lilly, Symbotic, Tesla: Why These 5 Stocks Are On Investors' Radars Today
February 05, 2024
U.S. stocks traded lower at the end of trading on Monday with the Dow Jones Industrial Average declining 0.7% to 38,380.12.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Healthcare And Life Science Funds And ETFs Performance 2023-2024
February 05, 2024
Healthcare stocks usually provide a defensive posture to a stock portfolio.
Via
Talk Markets
Topics
ETFs
3 High-Octane Growth Stocks Not Slowing Down Any Time Soon
February 05, 2024
These high-octane growth stocks provide the kind of upside long-term investors should want from higher-risk bets.
Via
InvestorPlace
NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?
February 05, 2024
The relaunch of Wegovy last year caused a mad dash by weight loss stocks to compete for market leadership in anti-obesity drugs.
Via
InvestorPlace
Amgen Is Trying To Take On Lilly, Novo In Obesity Treatment — Here's Why Lilly Stock Just Hit A Record
February 05, 2024
Amgen is looking to rival Eli Lilly and Novo Nordisk in weight-loss drugs.
Via
Investor's Business Daily
Eli Lilly and Company (NYSE: LLY) is a Leading Gainer in Monday Morning Trading
February 05, 2024
Via
Investor Brand Network
In-Depth Analysis: Eli Lilly Versus Competitors In Pharmaceuticals Industry
February 05, 2024
Via
Benzinga
Is It Too Late to Buy Eli Lilly Stock?
February 05, 2024
Growth may slow, and its valuation is looking precarious.
Via
The Motley Fool
Earnings Scheduled For February 6, 2024
February 06, 2024
Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion.
Via
Benzinga
Investor Sentiment Improves Following Services PMI; S&P 500 Slips From Record Levels
February 06, 2024
The CNN Money Fear and Greed index showed further improvement in overall market sentiment, but it remained in the "Greed" zone on Monday. U.S. stocks closed lower on Monday, with the S&P 500 index...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Ford, Eli Lilly And 3 Stocks To Watch Heading Into Tuesday
February 06, 2024
With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Eli Lilly Likely To Report Higher Q4 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
February 06, 2024
Eli Lilly and Company (NYSE: LLY) is expected to release earnings results for its fourth quarter, before the opening bell on Feb. 6, 2024.
Via
Benzinga
Markets Take A Powder; PLTR, NXPI Beat In Q4
February 06, 2024
We finished the normal trading session on the first day of a new trading week the same way we began it — reluctant to drag a stock market higher amid all-time high ranges on the Dow and S&P 500,...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Market Whales and Their Recent Bets on LLY Options
February 01, 2024
Via
Benzinga
Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 05, 2024
Shares of Air Products and Chemicals, Inc. (NYSE: APD) fell sharply during Monday’s session after the company reported worse-than-expected first-quarter financial results and lowered FY24 adjusted EPS...
Via
Benzinga
What's Going On With Eli Lilly Stock Today?
February 05, 2024
Eli Lilly's stock surge, driven by the upcoming Q4 2023 results and the impact of FDA-approved weight-loss drug Zepbound.
Via
Benzinga
Markets suddenly price Eli Lilly stock for a breakout on earnings
February 05, 2024
The healthcare sector could see a sudden inflow of investment dollars, and Eli Lilly quickly becomes a favorite name in the space as markets and analysts bid up
Via
MarketBeat
Topics
Bonds
Economy
Exposures
Debt Markets
Interest Rates
Novo Nordisk To Up Production Capacity As Parent Buys Catalent
February 05, 2024
NVO stock rose after Novo Nordisk's parent, Novo Holdings, said it has agreed to buy contract manufacturer Catalent for $11.5 billion in cash.
Via
Investor's Business Daily
Estée Lauder Posts Upbeat Earnings, Joins ON Semiconductor, Tyson Foods And Other Big Stocks Moving Higher On Monday
February 05, 2024
U.S. stocks traded lower, with the Dow Jones falling over 300 points on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Weight Loss Drug's New Entrant: Amgen To Compete With Novo Nordisk, Eli Lilly, As Investigational Weight Loss Drug Shows Encouraging Early Data
February 05, 2024
Amgen's AMG 133 data. Promising results in obesity drug trials, including significant weight loss and improved metabolic markers.
Via
Benzinga
How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q4 Earnings Report
February 05, 2024
Eli Lilly and Company (NYSE: LLY) is expected to release earnings results for its fourth quarter, before the opening bell on Feb. 6, 2024.
Via
Benzinga
After a 90% Gain, Is It Too Late to Buy Eli Lilly?
February 04, 2024
Its drug tirzepatide showed top efficacy as a weight-loss treatment according to the latest real-world data.
Via
The Motley Fool
7 Mutual Funds That Will Outperform in Any Market
February 03, 2024
While we’d all love to think we’re market geniuses, we could use the active management of outperforming mutual funds.
Via
InvestorPlace
SPDR ETF Report For Friday, February 2
February 03, 2024
In this video, Ira Epstein reviews the day's trading in various SPDR-ETF markets for the trading day just ended, Friday, February 2.
Via
Talk Markets
Topics
ETFs
3 Pharma Stocks to Sell in February Before They Crash and Burn
February 02, 2024
The good times are coming to an end for these overpriced pharma stocks to sell this month before they crash and burn.
Via
InvestorPlace
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
The Inflation Reduction Act's impact on drug prices. Medicare challenges pharmaceutical costs, offering relief to seniors and addressing the soaring prices in the U.S. healthcare system.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
What's Going On With Eli Lilly Stock Today?
February 02, 2024
Eli Lilly reveals Q4 2023 results on Feb 6. Analysts anticipate $2.19 EPS, $8.932 billion in sales. Explore recent developments and FDA inspection.
Via
Benzinga
Exposures
Product Safety
The Road to a Trillion: 3 Stocks Next in Line for the Mega Milestone
February 01, 2024
Becoming a trillion-dollar milestone stock is more than just having a title. Rather, it indicates market dominance in the industry.
Via
InvestorPlace
Eli Lilly To Report Q4 Earnings: What's In The Cards?
February 01, 2024
We expect Eli Lilly & Company to beat expectations when it reports fourth-quarter and full-year 2023 results on Feb 6, before the market open.
Via
Talk Markets
Why Eli Lilly Stock Topped the Market Today
January 31, 2024
One of its more recently approved drugs will be launched into a white-hot market.
Via
The Motley Fool
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
98
99
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.